Slavica Vuckovic

Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib

J. Whitehead, W. Sanchez, S. McGee, 2013, British Journal of Cancer.

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.

P. L. Bergsagel, S. Masters, H. Avet-Loiseau, 2018, Cancer cell.

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.

Deborah S. Barkauskas, P. L. Bergsagel, M. Lazar, 2019, JCI insight.

Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD

J. P. Martins, G. Hill, S. Durrant, 2016, Bone Marrow Transplantation.